Cart
sales@molnova.com
AMAS
CAS No. 55750-61-3
AMAS ( —— )
Catalog No. M26879 CAS No. 55750-61-3
AMAS is a nonclaevable heterobifunctional crosslinker with NHS ester and maleimide groups that allows covalent conjugation of amine- and sulfhydryl-containing molecules.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 38 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAMAS
-
NoteResearch use only, not for human use.
-
Brief DescriptionAMAS is a nonclaevable heterobifunctional crosslinker with NHS ester and maleimide groups that allows covalent conjugation of amine- and sulfhydryl-containing molecules.
-
DescriptionAMAS is a nonclaevable heterobifunctional crosslinker with NHS ester and maleimide groups that allows covalent conjugation of amine- and sulfhydryl-containing molecules.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorApoptosis; PGE2; Wnt/β-catenin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55750-61-3
-
Formula Weight252.2
-
Molecular FormulaC10H8N2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(CN1C(=O)C=CC1=O)ON1C(=O)CCC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Majchrzak-Celińska A, et al. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells. BMC Cancer. 2021 May 3;21(1):493.
molnova catalog
related products
-
Dimethyl-d6 Sulfoxid...
Dimethyl-d6 Sulfoxide is a form in which hydrogen ("H") of dimethyl sulfoxide (DMSO, (CH3) 2S = O) is replaced by another isotope deuterium ("d").
-
RBN013209
RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
-
L-Hydroxyprolin
L-Hydroxyproline, one of the hydroxyproline (Hyp) isomers, is a useful chiral building block in the production of many pharmaceuticals.
